Pioglitazone prevents intimal hyperplasia in experimental rabbit vein grafts

Journal of Vascular Surgery

Volumn 54, Issue 6, 2011, Pages 1753-1759

  Morisaki, Koichi ^a   Shibata, Rei ^a   Takahashi, Noriko ^a   Ouchi, Noriyuki ^a   Maehara, Yoshihiko ^b   Murohara, Toyoaki ^a   Komori, Kimihiro ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE KINASE; ADIPONECTIN; CHOLESTEROL; DNA NUCLEOTIDYLEXOTRANSFERASE; GLUCOSE; MITOGEN ACTIVATED PROTEIN KINASE; MONOCLONAL ANTIBODY KI 67; PIOGLITAZONE; VASCULAR TARGETING AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL FOOD; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD SAMPLING; CELL COUNT; CELL PROLIFERATION; CHOLESTEROL BLOOD LEVEL; COMMON CAROTID ARTERY; CONTROLLED STUDY; DRUG EFFECT; ENZYME PHOSPHORYLATION; EXPERIMENTAL RABBIT; EXTERNAL JUGULAR VEIN; GLUCOSE BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; MALE; NEOINTIMA; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; VEIN BYPASS; VEIN GRAFT DISEASE; WESTERN BLOTTING;

ANIMALS; CAROTID ARTERY, COMMON; HYPERPLASIA; HYPOGLYCEMIC AGENTS; JUGULAR VEINS; MALE; MODELS, ANIMAL; RABBITS; THIAZOLIDINEDIONES; TUNICA INTIMA; VASCULAR GRAFTING;

EID: 82955187046     PISSN: 07415214     EISSN: 10976809     Source Type: Journal    
DOI: 10.1016/j.jvs.2011.06.081     Document Type: Article

References (39)

1. L.L. Nguyen, M.S. Conte, M.T. Menard, E.C. Gravereaux, D.K. Chew, and M.C. Donaldson Infrainguinal vein bypass graft revision: factors affecting long-term outcome J Vasc Surg 40 2004 916 923 (Pubitemid 39535221)
2. P. Klinkert, P.N. Post, P.J. Breslau, and J.H. van Bockel Saphenous vein versus PTFE for above-knee femoropopliteal bypass A review of the literature Eur J Vasc Endovasc Surg 27 2004 357 362 (Pubitemid 38386920)
3. J.G. Motwani, and E.J. Topol Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention Circulation 97 1998 916 931 (Pubitemid 28113931)
4. H. Yki-Jrvinen Thiazolidinediones N Engl J Med 351 2004 1106 1118
5. J.A. Dormandy, B. Charbonnel, D.J. Eckland, E. Erdmann, M. Massi-Benedetti, and I.K. Moules Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial Lancet 366 2005 1279 1289 (Pubitemid 41416583)
6. A.M. Lincoff, K. Wolski, S.J. Nicholls, and S.E. Nissen Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials JAMA 298 2007 1180 1188 (Pubitemid 47403104)
7. N. Marx, J. Wöhrle, T. Nusser, D. Walcher, A. Rinker, and V. Hombach Pioglitazone reduces neointima volume after coronary stent implantation: a randomized, placebo-controlled, double-blind trial in nondiabetic patients Circulation 112 2005 2792 2798 (Pubitemid 41641673)
8. Y. Aizawa, J. Kawabe, N. Hasebe, N. Takehara, and K. Kikuchi Pioglitazone enhances cytokine-induced apoptosis in vascular smooth muscle cells and reduces intimal hyperplasia Circulation 104 2001 455 460 (Pubitemid 32678277)
9. T. Kasai, K. Miyauchi, T. Yokoyama, K. Kajimoto, K. Sumiyoshi, and N. Kubota Pioglitazone attenuates neointimal thickening via suppression of the early inflammatory response in a porcine coronary after stenting Atherosclerosis 197 2008 612 619 (Pubitemid 351417907)
10. C.V. Desouza, M. Gerety, and F.G. Hamel Long-term effects of a PPAR-gamma agonist, pioglitazone, on neointimal hyperplasia and endothelial regrowth in insulin resistant rats Vascul Pharmacol 46 2007 188 194 (Pubitemid 46096813)
11. N. Marx, U. Schönbeck, M.A. Lazar, P. Libby, and J. Plutzky Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells Circ Res 83 1998 1097 1103 (Pubitemid 28533518)
12. S.T. de Dios, D. Bruemmer, R.J. Dilley, M.E. Ivey, G.L. Jennings, and R.E. Law Inhibitory activity of clinical thiazolidinedione peroxisome proliferator activating receptor-gamma ligands toward internal mammary artery, radial artery, and saphenous vein smooth muscle cell proliferation Circulation 107 2003 2548 2550 (Pubitemid 36628933)
13. M. Shimano, Y. Tsuji, Y. Inden, K. Kitamura, T. Uchikawa, and S. Harata Pioglitazone, a peroxisome proliferator-activated receptor-gamma activator, attenuates atrial fibrosis and atrial fibrillation promotion in rabbits with congestive heart failure Heart Rhythm 5 2008 451 459
14. P. Li, R. Shibata, K. Unno, M. Shimano, M. Furukawa, and T. Ohashi Evidence for the importance of adiponectin in the cardioprotective effects of pioglitazone Hypertension 55 2010 69 75
15. A. Kodama, K. Komori, K. Hattori, D. Yamanouchi, J. Kajikuri, and T. Itoh Sarpogrelate hydrochloride reduced intimal hyperplasia in experimental rabbit vein graft J Vasc Surg 49 2009 1272 1281
16. T. Furuyama, K. Komori, H. Shimokawa, Y. Matsumoto, T. Uwatoku, and K. Hirano Long-term inhibition of Rho kinase suppresses intimal thickening in autologous vein grafts in rabbits J Vasc Surg 43 2006 1249 1256 (Pubitemid 43825685)
17. K. Hattori, D. Yamanouchi, H. Banno, M. Kobayashi, K. Yamamoto, and J. Kajikuri Celiprolol reduces the intimal thickening of autogenous vein grafts via an enhancement of nitric oxide function through an inhibition of superoxide production J Vasc Surg 46 2007 116 123 (Pubitemid 46990765)
18. H. Waki, T. Yamauchi, J. Kamon, Y. Ito, S. Uchida, and S. Kita Impaired multimerization of human adiponectin mutants associated with diabetes Molecular structure and multimer formation of adiponectin J Biol Chem 278 2003 40352 40363 (Pubitemid 37248604)
19. G.H. Gibbons, and V.J. Dzau The emerging concept of vascular remodeling N Engl J Med 330 1994 1431 1438 (Pubitemid 24139238)
20. M. Ishida, K. Komori, Y. Yonemitsu, K. Taguchi, T. Onohara, and K. Sugimachi Immunohistochemical phenotypic alterations of rabbit autologous vein grafts implanted under arterial circulation with or without poor distal runoff-implications of vein graft remodeling Atherosclerosis 154 2001 345 354 (Pubitemid 32146607)
21. M.G. Davies, and P.O. Hagen Pathophysiology of vein graft failure: a review Eur J Vasc Endovasc Surg 9 1995 7 18
22. D. Nagata, R. Takeda, M. Sata, H. Satonaka, E. Suzuki, and T. Nagano AMP-activated protein kinase inhibits angiotensin II-stimulated vascular smooth muscle cell proliferation Circulation 110 2004 444 451 (Pubitemid 38993855)
23. M. Igata, H. Motoshima, K. Tsuruzoe, K. Kojima, T. Matsumura, and T. Kondo Adenosine monophosphate-activated protein kinase suppresses vascular smooth muscle cell proliferation through the inhibition of cell cycle progression Circ Res 97 2005 837 844 (Pubitemid 41447135)
24. N. Maeda, M. Takahashi, T. Funahashi, S. Kihara, H. Nishizawa, and K. Kishida PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein Diabetes 50 2001 2094 2099 (Pubitemid 33643677)
25. M. Iwaki, M. Matsuda, N. Maeda, T. Funahashi, Y. Matsuzawa, and M. Makishima Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors Diabetes 52 2003 1655 1663 (Pubitemid 36792453)
26. N. Ouchi, S. Kihara, Y. Arita, K. Maeda, H. Kuriyama, and Y. Okamoto Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin Circulation 100 1999 2473 2476 (Pubitemid 30005109)
27. Y. Iwashima, T. Horio, Y. Suzuki, S. Kihara, H. Rakugi, and K. Kangawa Adiponectin and inflammatory markers in peripheral arterial occlusive disease Atherosclerosis 188 2006 384 390 (Pubitemid 44301128)
28. N. Maeda, I. Shimomura, K. Kishida, H. Nishizawa, M. Matsuda, and H. Nagaretani Diet-induced insulin resistance in mice lacking adiponectin/ACRP30 Nat Med 8 2002 731 737 (Pubitemid 34778727)
29. Y. Okamoto, S. Kihara, N. Ouchi, M. Nishida, Y. Arita, and M. Kumada Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice Circulation 106 2002 2767 2770 (Pubitemid 35396973)
30. M. Matsuda, I. Shimomura, M. Sata, Y. Arita, M. Nishida, and N. Maeda Role of adiponectin in preventing vascular stenosis The missing link of adipo-vascular axis J Biol Chem 277 2002 37487 37491
31. N. Ouchi, M. Ohishi, S. Kihara, T. Funahashi, T. Nakamura, and H. Nagaretani Association of hypoadiponectinemia with impaired vasoreactivity Hypertension 42 2003 231 234 (Pubitemid 37093465)
32. R. Shibata, N. Ouchi, S. Kihara, K. Sato, T. Funahashi, and K. Walsh Adiponectin stimulates angiogenesis in response to tissue ischemia through stimulation of amp-activated protein kinase signaling J Biol Chem 279 2004 28670 28674 (Pubitemid 38900150)
33. R. Shibata, K. Sato, D.R. Pimentel, Y. Takemura, S. Kihara, and K. Ohashi Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms Nat Med 11 2005 1096 1103 (Pubitemid 41486832)
34. R. Shibata, N. Ouchi, M. Ito, S. Kihara, I. Shiojima, and D.R. Pimentel Adiponectin-mediated modulation of hypertrophic signals in the heart Nat Med 10 2004 1384 1389 (Pubitemid 40022722)
35. M.B. Yilmaz, U. Guray, Y. Guray, S.F. Biyikoglu, I. Tandogan, and H. Sasmaz Metabolic syndrome negatively impacts early patency of saphenous vein grafts Coron Artery Dis 17 2006 41 44 (Pubitemid 44365919)
36. M.T. Selcuk, H. Selcuk, O. Maden, O. Ozeke, H. Ulupinar, and A. Temizhan Effect of obesity on saphenous vein graft stenosis in patients with postoperative recurrent angina Acta Cardiol 62 2007 397 402 (Pubitemid 47310626)
37. T. Shiomi, H. Tsutsui, S. Hayashidani, N. Suematsu, M. Ikeuchi, and J. Wen Pioglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates left ventricular remodeling and failure after experimental myocardial infarction Circulation 106 2002 3126 3132 (Pubitemid 35440299)
38. A. Higuchi, K. Ohashi, R. Shibata, S. Sono-Romanelli, K. Walsh, and N. Ouchi Thiazolidinediones reduce pathological neovascularization in ischemic retina via an adiponectin-dependent mechanism Arterioscler Thromb Vasc Biol 30 2010 46 53
39. T. Tanaka, Y. Fukunaga, H. Itoh, K. Doi, J. Yamashita, and T.H. Chun Therapeutic potential of thiazolidinediones in activation of peroxisome proliferator-activated receptor gamma for monocyte recruitment and endothelial regeneration Eur J Pharmacol 508 2005 255 265 (Pubitemid 40169927)